
Angela A. Armstrong
Examiner (ID: 7226, Phone: (571)272-7598 , Office: P/2659 )
| Most Active Art Unit | 2659 |
| Art Unit(s) | 2659, 2641, 2741, 2654, 2626 |
| Total Applications | 1003 |
| Issued Applications | 675 |
| Pending Applications | 123 |
| Abandoned Applications | 230 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6275300
[patent_doc_number] => 20100256070
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-07
[patent_title] => 'RECOMBINANT VIBRIO CHOLERAE EXOTOXINS'
[patent_app_type] => utility
[patent_app_number] => 12/669712
[patent_app_country] => US
[patent_app_date] => 2008-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 34139
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20100256070.pdf
[firstpage_image] =>[orig_patent_app_number] => 12669712
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/669712 | Fusion proteins comprising a fragment of Vibrio cholerae exotoxin A | Jul 17, 2008 | Issued |
Array
(
[id] => 6275300
[patent_doc_number] => 20100256070
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-07
[patent_title] => 'RECOMBINANT VIBRIO CHOLERAE EXOTOXINS'
[patent_app_type] => utility
[patent_app_number] => 12/669712
[patent_app_country] => US
[patent_app_date] => 2008-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 34139
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20100256070.pdf
[firstpage_image] =>[orig_patent_app_number] => 12669712
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/669712 | Fusion proteins comprising a fragment of Vibrio cholerae exotoxin A | Jul 17, 2008 | Issued |
Array
(
[id] => 6275300
[patent_doc_number] => 20100256070
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-07
[patent_title] => 'RECOMBINANT VIBRIO CHOLERAE EXOTOXINS'
[patent_app_type] => utility
[patent_app_number] => 12/669712
[patent_app_country] => US
[patent_app_date] => 2008-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 34139
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20100256070.pdf
[firstpage_image] =>[orig_patent_app_number] => 12669712
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/669712 | Fusion proteins comprising a fragment of Vibrio cholerae exotoxin A | Jul 17, 2008 | Issued |
Array
(
[id] => 6275300
[patent_doc_number] => 20100256070
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-07
[patent_title] => 'RECOMBINANT VIBRIO CHOLERAE EXOTOXINS'
[patent_app_type] => utility
[patent_app_number] => 12/669712
[patent_app_country] => US
[patent_app_date] => 2008-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 34139
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20100256070.pdf
[firstpage_image] =>[orig_patent_app_number] => 12669712
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/669712 | Fusion proteins comprising a fragment of Vibrio cholerae exotoxin A | Jul 17, 2008 | Issued |
Array
(
[id] => 11191548
[patent_doc_number] => 09422349
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-23
[patent_title] => 'N-terminal modified exendin-4'
[patent_app_type] => utility
[patent_app_number] => 12/669372
[patent_app_country] => US
[patent_app_date] => 2008-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4245
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12669372
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/669372 | N-terminal modified exendin-4 | Jul 15, 2008 | Issued |
Array
(
[id] => 4960548
[patent_doc_number] => 20080274973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-06
[patent_title] => ' NOVEL HAEMOPOIETIN RECEPTOR AND GENETIC SEQUENCES ENCODING SAME'
[patent_app_type] => utility
[patent_app_number] => 12/165993
[patent_app_country] => US
[patent_app_date] => 2008-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 14294
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20080274973.pdf
[firstpage_image] =>[orig_patent_app_number] => 12165993
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/165993 | NOVEL HAEMOPOIETIN RECEPTOR AND GENETIC SEQUENCES ENCODING SAME | Jun 30, 2008 | Abandoned |
Array
(
[id] => 8858786
[patent_doc_number] => 08461321
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-11
[patent_title] => 'Nucleic acids encoding a deletion variant of uPAR'
[patent_app_type] => utility
[patent_app_number] => 12/164881
[patent_app_country] => US
[patent_app_date] => 2008-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 9845
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12164881
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/164881 | Nucleic acids encoding a deletion variant of uPAR | Jun 29, 2008 | Issued |
Array
(
[id] => 6320721
[patent_doc_number] => 20100196412
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'HOMOGENEOUS VACCINE COMPOSITION FOR THE TUMOR TREATMENT AND ITS OBTAINING METHOD'
[patent_app_type] => utility
[patent_app_number] => 12/664545
[patent_app_country] => US
[patent_app_date] => 2008-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5368
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20100196412.pdf
[firstpage_image] =>[orig_patent_app_number] => 12664545
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/664545 | Homogeneous vaccine composition comprising a conjugate of EGF and P64K for the treatment of tumors | Jun 25, 2008 | Issued |
Array
(
[id] => 4792943
[patent_doc_number] => 20080293917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-27
[patent_title] => 'Peptide Purification By Means Of Metal Ion Affinity Chromatography'
[patent_app_type] => utility
[patent_app_number] => 12/143905
[patent_app_country] => US
[patent_app_date] => 2008-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 58
[patent_figures_cnt] => 58
[patent_no_of_words] => 54004
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20080293917.pdf
[firstpage_image] =>[orig_patent_app_number] => 12143905
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/143905 | Peptide Purification By Means Of Metal Ion Affinity Chromatography | Jun 22, 2008 | Abandoned |
Array
(
[id] => 5284871
[patent_doc_number] => 20090098546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-16
[patent_title] => 'Methods of Screening for LTRPC7 Modulators'
[patent_app_type] => utility
[patent_app_number] => 12/128471
[patent_app_country] => US
[patent_app_date] => 2008-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 17850
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20090098546.pdf
[firstpage_image] =>[orig_patent_app_number] => 12128471
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/128471 | Methods of screening for LTRPC7 modulators | May 27, 2008 | Issued |
Array
(
[id] => 5265496
[patent_doc_number] => 20090118181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-07
[patent_title] => 'Compositions and methods for producing bioactive fusion proteins'
[patent_app_type] => utility
[patent_app_number] => 12/154507
[patent_app_country] => US
[patent_app_date] => 2008-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 37195
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20090118181.pdf
[firstpage_image] =>[orig_patent_app_number] => 12154507
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/154507 | Compositions and methods for producing bioactive fusion proteins | May 21, 2008 | Issued |
Array
(
[id] => 6144505
[patent_doc_number] => 20110130347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-02
[patent_title] => 'IDENTIFICATION OF NEW SPLICE-VARIANTS OF G-PROTEIN COUPLED RECEPTOR EP3 AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/602767
[patent_app_country] => US
[patent_app_date] => 2008-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 100
[patent_figures_cnt] => 100
[patent_no_of_words] => 33973
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20110130347.pdf
[firstpage_image] =>[orig_patent_app_number] => 12602767
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/602767 | IDENTIFICATION OF NEW SPLICE-VARIANTS OF G-PROTEIN COUPLED RECEPTOR EP3 AND USES THEREOF | May 19, 2008 | Abandoned |
Array
(
[id] => 6101681
[patent_doc_number] => 20110165173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-07
[patent_title] => 'THERAPEUTIC AGENT AND DETECTION REAGENT FOR ARTERIOSCLEROTIC DISEASE WHICH TARGETS FOR SALUSIN'
[patent_app_type] => utility
[patent_app_number] => 12/599732
[patent_app_country] => US
[patent_app_date] => 2008-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 15674
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20110165173.pdf
[firstpage_image] =>[orig_patent_app_number] => 12599732
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/599732 | THERAPEUTIC AGENT AND DETECTION REAGENT FOR ARTERIOSCLEROTIC DISEASE WHICH TARGETS FOR SALUSIN | May 8, 2008 | Abandoned |
Array
(
[id] => 5485739
[patent_doc_number] => 20090275504
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'PCSK9 PROTEINS, FRAGMENTS THEREOF AND METHODS OF MODULATING PCSK9 PHOSPHORYLATION AND LOW DENSITY LIPOPROTEIN (LDLR) DEGRADATION'
[patent_app_type] => utility
[patent_app_number] => 12/115382
[patent_app_country] => US
[patent_app_date] => 2008-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 16115
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20090275504.pdf
[firstpage_image] =>[orig_patent_app_number] => 12115382
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/115382 | PCSK9 polypeptide fragment | May 4, 2008 | Issued |
Array
(
[id] => 6516414
[patent_doc_number] => 20100261654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-14
[patent_title] => 'COMPOSITIONS AND METHODS FOR INCREASING VASCULARIZATION'
[patent_app_type] => utility
[patent_app_number] => 12/598293
[patent_app_country] => US
[patent_app_date] => 2008-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8696
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20100261654.pdf
[firstpage_image] =>[orig_patent_app_number] => 12598293
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/598293 | Methods for increasing vascularization | Apr 30, 2008 | Issued |
Array
(
[id] => 4699121
[patent_doc_number] => 20080221305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-11
[patent_title] => 'Polynucleotides encoding novel adiponectin receptor variants'
[patent_app_type] => utility
[patent_app_number] => 12/148669
[patent_app_country] => US
[patent_app_date] => 2008-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 151796
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20080221305.pdf
[firstpage_image] =>[orig_patent_app_number] => 12148669
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/148669 | Adiponectin receptor variant, AdipoR2v2 | Apr 20, 2008 | Issued |
Array
(
[id] => 6391746
[patent_doc_number] => 20100303793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-02
[patent_title] => 'COMBINATION THERAPY FOR CARDIAC REVASCULARIZATION AND CARDIAC REPAIR'
[patent_app_type] => utility
[patent_app_number] => 12/595343
[patent_app_country] => US
[patent_app_date] => 2008-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 19504
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0303/20100303793.pdf
[firstpage_image] =>[orig_patent_app_number] => 12595343
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/595343 | COMBINATION THERAPY FOR CARDIAC REVASCULARIZATION AND CARDIAC REPAIR | Apr 9, 2008 | Abandoned |
Array
(
[id] => 6343034
[patent_doc_number] => 20100330028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-30
[patent_title] => 'COMBINATION THERAPY FOR CHRONIC DERMAL ULCERS'
[patent_app_type] => utility
[patent_app_number] => 12/595051
[patent_app_country] => US
[patent_app_date] => 2008-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18759
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0330/20100330028.pdf
[firstpage_image] =>[orig_patent_app_number] => 12595051
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/595051 | COMBINATION THERAPY FOR CHRONIC DERMAL ULCERS | Apr 9, 2008 | Abandoned |
Array
(
[id] => 5546589
[patent_doc_number] => 20090156466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-18
[patent_title] => 'Characterization of a MEKK binding site and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/078808
[patent_app_country] => US
[patent_app_date] => 2008-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8347
[patent_no_of_claims] => 124
[patent_no_of_ind_claims] => 105
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20090156466.pdf
[firstpage_image] =>[orig_patent_app_number] => 12078808
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/078808 | Characterization of a MEKK binding site and uses thereof | Apr 3, 2008 | Abandoned |
Array
(
[id] => 4949875
[patent_doc_number] => 20080306001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-11
[patent_title] => 'TRANSCRIPTIONAL MODULATION OF EXTRACELLULAR MATRIX (ECM) OF DERMAL FIBROBLASTS'
[patent_app_type] => utility
[patent_app_number] => 12/062155
[patent_app_country] => US
[patent_app_date] => 2008-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9764
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20080306001.pdf
[firstpage_image] =>[orig_patent_app_number] => 12062155
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/062155 | TRANSCRIPTIONAL MODULATION OF EXTRACELLULAR MATRIX (ECM) OF DERMAL FIBROBLASTS | Apr 2, 2008 | Abandoned |